维普中文期刊产品整合服务

Beta-blocker treatment in heart failure patients with atrial fibrillation:challenges and perspectives

查看全文 作　　者：Emmanouil [1]Chourdakis;Ioanna [2]Koniari;Dimitrios [3]Velissaris;Grigorios [4]Tsigkas;Nikolaos G [4]Kounis;Neriman [1]Osman 高影响力作者 机构地区：[1]Krankenhaus der Barmherzigen Brüder Trier,Germany;[2]Manchester Heart Institute,Manchester University Foundation Trust,Manchester,United Kingdom;[3]Department of Internal Medicine,University Hospital of Patras,Patras,Greece;[4]Cardiology Department,University Hospital of Patras,Patras,Greece高影响力机构 出　　处：《Journal of Geriatric Cardiology》索引2021年第18卷第5期,共14页高影响力期刊 摘　　要：Heart failure(HF)and atrial fibrillation(AF)are common conditions that share similar clinical phenotype and frequently coexist.The classification of HF in patients with preserved ejection fraction(>50%,HFpEF),midrange reduced EF(40%−49%,HFmrEF)and reduced EF(<40%,HFrEF)are crucial for optimising the therapeutic approach,as each subgroup responds differently.Betablocker constitute an important component of our pharmacological regimen for chronic HF.Betablocker administration is reccomended in patients with HF with reduced ejection fraction in stable sinus rhythm,due to improvement of symptoms,the better long termoutcome and survival.The beneficial role of betablocker use in patients with preserved EF still remain unclear,as no treatment showed a positive impact,regarding morbidity or mortality reduction.The presence of AF in HF patients increases as the disease severity evolves and is associated with a higher rate of cardiovascular morbidity and mortality.But more question is the use of betablocker in HF patients irrespective of EF and concomitant AF.There are many conflicting data and publications,regarding the beta blocker benefit in this population.Generally,it is supported an attenuation of betablockers beneficial effect in HF patients with AF.A design of more randomised trials/studies with HF patients and concomitant AF may improve our clinical approach of betablockers use and identify the patients with HF,who mostly profit from an invasive approach. 关 键 词：TREATMENT evolve mostly
相关文献

参考文献(140)

引证文献(4)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费